Fundraising FoxBioPharmX
Menlo Park, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into BioPharmX
Sign up to see every warm intro you have to BioPharmX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioPharmX team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BioPharmX was founded in 2014 by Anja Krammer and JAMES PEKARSKY.
AK
Anja KrammerPresident and Director
JP
JAMES PEKARSKYCEO and CFO
GK
Greg KitchenerChief Financial Officer
Board
MH
Michael HubbardChairman
SM
Stephen MorlockBoard director
Investors · 1
Korea Investment PartnersreportedSeoul · $3M – $10M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 7 of 8 rounds · 2012–2022
▶Undisclosed amountofferedOct 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶Undisclosed amountofferedOct 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LuccheseExecutive Officer
- Alan M. MendelsohnExecutive Officer
- Edward J. SitarDirector
- David E. CohenDirector
- Lubor GaalDirector
- John KoconisExecutive Officer, Director
- Gianluca PirozziDirector
- Placement agents
- H.C. Wainwright & Co. LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$930KraisedOct 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$930KraisedOct 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Greg KitchenerExecutive Officer
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Stephen MorlockDirector
- Offering amount
- $930K
- Amount sold
- $930K
- Sales commissions
- $55.8K
- Placement agents
- Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$508.5KraisedMar 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$508.5KraisedMar 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anja KrammerExecutive Officer, Director
- Kin ChanExecutive Officer
- Michael HubbardDirector
- Ping WangDirector
- James PekarskyExecutive Officer, Director
- Offering amount
- $508.5K
- Amount sold
- $508.5K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7.9MraisedMar 2015 · 51 investors · PharmaceuticalsRule 506(b)
▶$7.9MraisedMar 2015 · 51 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JAMES PEKARSKYExecutive Officer, Director
- PING WANGDirector
- ANJA KRAMMERExecutive Officer, Director
- KIN CHANExecutive Officer
- MICHAEL HUBBARDDirector
- Offering amount
- $18.6M
- Amount sold
- $7.9M
- Finders' fees
- $227.2K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- James PekarskyExecutive Officer, Director
- Kin ChanExecutive Officer
- Ping WangDirector
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Offering amount
- $134.3K
- Amount sold
- $134.3K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 05
▶$1.8MraisedMar 2015 · 25 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedMar 2015 · 25 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ping WangDirector
- James PekarskyExecutive Officer, Director
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Kin ChanExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Aug 2012
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7KraisedJan 2014 · 4 investors · PharmaceuticalsRule 506(b)
▶$7KraisedJan 2014 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ANJA KRAMMERExecutive Officer, Director
- JAMES PEKARSKYExecutive Officer, Director
- Offering amount
- $7K
- Amount sold
- $7K
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2010
- Federal exemptions
- 06b
▶$500KraisedJan 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedJan 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JAMES PEKARSKYExecutive Officer, Director
- ANJA KRAMMERExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded BioPharmX?
- BioPharmX was founded by Anja Krammer, JAMES PEKARSKY in 2014.
- Who are BioPharmX's investors?
- BioPharmX's investors include Korea Investment Partners.
- How much funding has BioPharmX raised?
- BioPharmX has disclosed $11.7M raised across 7 of its 8 known rounds.
- Where is BioPharmX headquartered?
- BioPharmX is headquartered in Menlo Park, US.